Insulet Stock Price To Earnings To Growth
| PODD Stock | USD 166.19 2.02 1.23% |
Insulet fundamentals help investors to digest information that contributes to Insulet's financial success or failures. It also enables traders to predict the movement of Insulet Stock. The fundamental analysis module provides a way to measure Insulet's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Insulet stock.
Insulet | Price To Earnings To Growth |
Insulet Company Price To Earnings To Growth Analysis
Insulet's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Insulet Price To Earnings To Growth | 3.15 X |
Most of Insulet's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insulet is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Insulet Price To Earnings To Growth Driver Correlations
Understanding the fundamental principles of building solid financial models for Insulet is extremely important. It helps to project a fair market value of Insulet Stock properly, considering its historical fundamentals such as Price To Earnings To Growth. Since Insulet's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insulet's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insulet's interrelated accounts and indicators.
Click cells to compare fundamentals
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Insulet Price Earnings To Growth Ratio
Price Earnings To Growth Ratio |
|
Based on the latest financial disclosure, Insulet has a Price To Earnings To Growth of 3.1485 times. This is 343.45% higher than that of the Health Care Equipment & Supplies sector and 65.71% higher than that of the Health Care industry. The price to earnings to growth for all United States stocks is 35.61% higher than that of the company.
Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Insulet Fundamentals
| Return On Equity | 0.34 | ||||
| Return On Asset | 0.0609 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 12.37 B | ||||
| Shares Outstanding | 70.02 M | ||||
| Shares Owned By Insiders | 0.31 % | ||||
| Shares Owned By Institutions | 99.69 % | ||||
| Number Of Shares Shorted | 2.86 M | ||||
| Price To Book | 16.75 X | ||||
| Price To Sales | 7.23 X | ||||
| Revenue | 1.7 B | ||||
| Gross Profit | 805.6 M | ||||
| EBITDA | 220 M | ||||
| Net Income | 206.3 M | ||||
| Cash And Equivalents | 708.6 M | ||||
| Cash Per Share | 10.21 X | ||||
| Total Debt | 1.45 B | ||||
| Debt To Equity | 3.34 % | ||||
| Current Ratio | 4.69 X | ||||
| Book Value Per Share | 10.48 X | ||||
| Cash Flow From Operations | 145.4 M | ||||
| Short Ratio | 3.75 X | ||||
| Earnings Per Share | 2.94 X | ||||
| Price To Earnings To Growth | 3.15 X | ||||
| Target Price | 236.83 | ||||
| Number Of Employees | 3 K | ||||
| Beta | 1.0 | ||||
| Market Capitalization | 11.64 B | ||||
| Total Asset | 2.59 B | ||||
| Retained Earnings | (378 M) | ||||
| Working Capital | 1.13 B | ||||
| Current Asset | 190.76 M | ||||
| Current Liabilities | 65.16 M | ||||
| Net Asset | 2.59 B |
About Insulet Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insulet's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insulet using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insulet based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Insulet using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Insulet Piotroski F Score and Insulet Altman Z Score analysis. For information on how to trade Insulet Stock refer to our How to Trade Insulet Stock guide.Note that the Insulet information on this page should be used as a complementary analysis to other Insulet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Complementary Tools for Insulet Stock analysis
When running Insulet's price analysis, check to measure Insulet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insulet is operating at the current time. Most of Insulet's value examination focuses on studying past and present price action to predict the probability of Insulet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insulet's price. Additionally, you may evaluate how the addition of Insulet to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Insulet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insulet. If investors know Insulet will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insulet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.043 | Earnings Share 2.94 | Revenue Per Share 24.331 | Quarterly Revenue Growth 0.379 | Return On Assets 0.0609 |
The market value of Insulet is measured differently than its book value, which is the value of Insulet that is recorded on the company's balance sheet. Investors also form their own opinion of Insulet's value that differs from its market value or its book value, called intrinsic value, which is Insulet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insulet's market value can be influenced by many factors that don't directly affect Insulet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Insulet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insulet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insulet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.